US Stock MarketDetailed Quotes

CATX Perspective Therapeutics

Watchlist
  • 13.4900
  • -0.4700-3.37%
Close Aug 16 16:00 ET
  • 13.4900
  • 0.00000.00%
Post 20:02 ET
909.60MMarket Cap-8126P/E (TTM)

Perspective Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Perspective Therapeutics Q2 2024 Earnings Date

Currency：USDAug 12, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
135.63K
0
-135.63K
Miss Est.
-93.50%
--
-100.00%
EPS
-0.13
-0.18
-0.05
Miss Est.
+67.52%
+55.00%
-38.57%
Analyst Rating
Strong Buy

Aug 16, 2024

Perspective Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 120.050K--
--2024/Q3-- / 118.110K--
Aug 12, 20242024/Q2526.000K / 135.630K--
May 15, 20242024/Q1325.000K / 68.800K--
--2023/Q4-4.902M / 2.122M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 120.050K--
--2024/Q3-- / 118.110K--
Aug 12, 20242024/Q2526.000K / 135.630K--
May 15, 20242024/Q1325.000K / 68.800K--
--2023/Q4-4.902M / 2.122M--

Unlock Free Earnings Estimates

Perspective Therapeutics Earnings Reports

  • Perspective Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 13 16:10 ET

  • Perspective Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 15 22:44 ET

  • Perspective Therapeutics | 10-K: FY2023 Annual Report

    Mar 28 08:39 ET

  • Perspective Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 14, 2023 16:59 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 16, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg